The BPDCN Channel on VJHemOnc is supported by Menarini and Stemline Therapeutics. The supporters have no influence over the production of the content.
Welcome to The BPDCN Channel
Reporting from key international congresses and speaking with world-leading experts, VJHemOnc brings you the latest advances in blastic plasmacytoid dendritic cell neoplasm (BPDCN), a rare and aggressive hematological malignancy. The BPDCN Channel delivers regular video interviews, roundtable discussions, and podcasts, so that you can keep up-to-date with all the practice-changing developments in BPDCN.
Explore The BPDCN Channel to learn about the latest clinical trial updates and novel agents being investigated.